<DOC>
	<DOC>NCT01052467</DOC>
	<brief_summary>This non-interventional, prospective, non-controlled study of Xamiol® Gel, a fixed combination of calcipotriol and betamethason dipropionate, shall investigate in daily routine the efficacy, tolerability and changes in quality-of-life parameters in patients with scalp psoriasis</brief_summary>
	<brief_title>Topical Treatment of Scalp Psoriasis With the Fixed Combination of Calcipotriol and Betamethason (Xamiol® Gel)</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Calcipotriene</mesh_term>
	<criteria>Patients with scalp psoriasis if a treatment with Xamiol® gel is planned anyway Contraindications of Xamiol® Gel listed in the German package insert Pretreatment with Xamiol® within the last 4 weeks Systemic treatment of psoriasis UV light therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
</DOC>